טוען...
Guillain-Barré syndrome in a patient with multiple myeloma after bortezomib therapy: A case report
BACKGROUND: Bortezomib is a first-line drug approved for patients with multiple myeloma (MM) and has significantly increased their overall survival. However, bortezomib-induced peripheral neuropathy (PN) remains a significant side effect that has led to its discontinuation in some patients. Guillain...
שמור ב:
| הוצא לאור ב: | World J Clin Cases |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Baishideng Publishing Group Inc
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6789385/ https://ncbi.nlm.nih.gov/pubmed/31616710 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12998/wjcc.v7.i18.2905 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|